Skip to main content

Jason Butler

Analyst

Citizens JMP

Equibles does not estimate personal net worth.

About Jason Butler

Jason Butler is recorded as Analyst at Citizens JMP. Jason Butler has spoken on 11 earnings calls and 3 other investor events across 6 companies, most recently for CorMedix Inc. on November 12, 2026. Those appearances were for Halozyme Therapeutics, Inc. (HALO), PolyPid Ltd. (PYPD), Ironwood Pharmaceuticals Inc (IRWD), CorMedix Inc. (CRMD), Zevra Therapeutics, Inc. (ZVRA) and 1 other company. The companies whose calls Jason Butler spoke on are classified in the Healthcare sector.

Jason Butler on recent calls

“First, can you talk a little bit more about what you're doing to prepare for the Rosio profi launch? What is awareness of the product and the profi data now among potential prescribers?”
Analyst — Citizens JMP, CorMedix Inc. Q3 FY2026 Earnings Call ·
“Helen, now that you're several quarters past the last two acquisitions, what do you think your capacity is to bring in more synergistic technologies and what's your, you know, kind of perspective on priority there?”
Analyst — Citizens JMP, Halozyme Therapeutics, Inc. Q3 FY2026 Earnings Call ·
“One question for the company and then I have a couple for Dr. Joseph. Deco, can you maybe talk about the preclinical data you have generated so far and any data you have around the PK profile?”
Analyst — Citizens JMP, PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026 ·
“First one, when you think about the 2029 and after enhanced product profile, what do you expect to be the biggest products in that portfolio? And then when are they coming to essentially peak in your model?”
Analyst — Citizens JMP, Halozyme Therapeutics, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Citizens JMP

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity